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Pilomatrix carcinoma of the lacrimal caruncle:
a case report
Carcinoma pilomatricial da carúncula lacrimal: relato de caso
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ABSTRACT | A 45-year-old man presented with a 3-month
history of a mass located in the caruncle of his right eye. An
incisional biopsy had been performed one month prior by
another specialist, and the histopathology report showed
basal cell carcinoma. The mass was completely excised with
a 2 mm safety margin, and the large conjunctival defect was
reconstructed with one sheet of amniotic membrane allograft.
A histological diagnosis of pilomatrix carcinoma was established.
To prevent recurrence after surgery, we added bevacizumab
(25 mg/mL, 1.25 mg/mL per drop) eye drops four times per day
for three months. At the one-year follow-up, the patient showed
no evidence of local recurrence or distant metastasis after
initial excision and remains under close follow-up. Pilomatrix
carcinoma should be considered in the differential diagnosis
of a caruncular mass.
Keywords: Hair follicle; Hair diseases; Skin neoplasms; Pilomatrixoma; Carcinoma, basal cell; Lacrimal apparatus diseases;
Bevacizumab/administration & dosage; Diagnosis, Differential;
Humans
RESUMO | Um homem de 45 anos apresentou história de massa
na carúncula no olho direito durante 3 meses. Uma biópsia
incisional foi realizada 1 mês antes por outro especialista e o
laudo histopatológico mostrava carcinoma basocelular. A massa
foi completamente excisada, com uma margem de segurança de
2 mm, e a grande lesão conjuntival foi reconstruída com uma
folha de aloenxerto de membrana amniótica. Foi estabelecido
um diagnóstico histológico de carcinoma pilomatricial. Para
evitar a recorrência após a cirurgia, adicionamos colírio de
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bevacizumabe (25 mg/mL, 1,25 mg/mL por gota) quatro vezes
ao dia durante três meses. No seguimento de 1 ano, o paciente
não apresentou evidência de recidiva local ou metástase distante
após a excisão inicial e continua sob acompanhamento próximo.
O carcinoma pilomatricial deve ser considerado no diagnóstico
diferencial de uma massa caruncular.
Descritores: Folículo piloso; Doenças do cabelo; Neoplasias
cutâneas; Pilomatrixoma; Carcinoma basocelular; Doenças do
aparelho lacrimal; Bevacizumab/administração & dosagem;
Diagnóstico diferencial; Humanos

INTRODUCTION
Pilomatricoma is a rare, benign, slow-growing dermal
or subcutaneous tumor that occurs most commonly in
the head, neck, extremities, and trunk (1). In 1949, Lever
and Griesemer(2) proposed that this tumor originates
from hair matrix cells. In 1961, Forbis and Helwig (3)
proposed the currently accepted name of “pilomatri
coma”. In 1980, Lopansri and Mihm(4) identified ma
lignant transformations in these tumor cells, and they
described these transformations as “pilomatrix carcinoma” (PMC) or “calcifying epitheliocarcinoma of
Malherbe.” In the present report, we describe the
clinical and histological features in a very rare case of
malignant hair follicle tumor involving the conjunctiva.
To the best of our knowledge, this is the first report on
the PMC of the ocular surface.
CASE REPORT
A 45-year-old man presented with a nontender enlarged mass measuring approximately 15 mm × 15 mm
that had grown from the lacrimal caruncle of the right
eye for more than three months (Figure 1A). He did not
complain of pain or discharge from the mass. An inci-
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sional biopsy had been performed one month prior by
another specialist; the histopathology report showed the
presence of basal cell carcinoma. The patient had no
notable ophthalmic or medical history. During ocular
examination, visual acuity in both eyes was 10/10 (decimal scale), and extraocular movements were normal.
The surface of the pinkish mass was smooth without
visible vessels, and the well-demarcated lesion was not
connected to the surrounding skin. No other lesions
were present on the eyelid. The results of the anterior and posterior ocular examinations were normal.
Moreover, the patient’s general physical examination
results were normal, and there was no evidence of
preauricular or submandibular lymphadenopathy. The
patient underwent surgical excision and topical chemotherapy. Under general anesthesia, the mass and a
2 mm safety margin were completely excised and sent
for histopathological examination. Double freeze-thaw
cryotherapy was applied to the conjunctival borders and
the base of the mass. The large conjunctival defect was
reconstructed with one sheet of amniotic membrane
allograft secured with polyglactin sutures. Histopathological examinations revealed the subepithelial irregular
infiltration of basaloid cells with hyperchromatic, ovoid,
and vesicular nuclei, as well as limited cytoplasm in a
trabecular or nested pattern (Figure 2A). Some nests of
the basaloid cells showed central keratinization (Figure
2B). In some areas, enucleated “ghost” or “shadow” cells
were present with eosinophilic cytoplasm. These cells
appeared to have merged with basaloid cell groups
(Figures 2B and 2C). Focal giant cell reactions were detected, and no calcification was present. The invasion
of the surrounding tissue was observed in desmoplastic
stroma (Figure 2D). There were no retraction artifacts
between the basaloid cells and stroma. Mitoses were
frequently observed (average 20-25 per 10 high-power
fields in basaloid areas). No definite vascular or lymphatic permeations were identified. The Ki67 proliferation
index was 80%. Immunohistochemical analysis showed
diffuse positive reactions for Ber-EP4; however, there
were no positive reactions for EMA, p63, S100, CD56,
or CK20. A diagnosis of PMC was made on the basis of
patient age, tumor localization, and histomorphological
findings. The surgical margins were free of tumor cells.
The results of complete blood cell count, renal and liver
function tests, chest x-ray, and neck and abdomen ultrasound investigations were normal. The patient provided
informed consent for further treatment; thus, we administered bevacizumab (25 mg/mL, 1.25 mg/mL per drop)
eye drops four times per day for three months to prevent
154
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recurrence after surgery. At the one-year follow-up after
initial excision, the patient showed no evidence of local
recurrence or distant metastasis. The patient continues
to be closely monitored (Figures 1B and 1C).
DISCUSSION
The most common sites for PMCs are the head and
neck, followed by the upper extremities, trunk, and lower
extremities(5). In a review by Sia et al.(6), 6 cases were
reported to be PMCs among the 16 cases involving hair
follicle malignancies in the periorbital region. In that review, the upper lid was the most commonly affected
site by malignant hair follicle tumors, followed by the
lower lid, eyebrow, and medial canthal region. The lacrimal caruncle has a nonkeratinized epithelial lining that
is similar to the conjunctival epithelium(7). Developmentally, it constitutes a part of the lower lid; therefore, it
contains hair follicles, sebaceous glands, and sweat glands.

A
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Figure 1. A) Clinical appearance of nonpigmented solid neoplasm involving
the medial area of the epibulbar conjunctiva, plica, and caruncle of the
right eye. B) Satisfactory cosmetic and functional results at eight weeks
after tumor excision and amniotic membrane transplantation. C) No sign
of local recurrence at one year after surgery; mild ﬁbrosis is present in
the transplanted area.
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Figure 2. A) Tumor infiltration is present beneath the conjunctiva epithelium
(arrow) (H&E, ×40). B) Two types of tumor cells (basaloid [thin arrow] and
ghost [thick arrow] cells) can be observed, along with focal keratinization
(arrowhead) (H&E, ×400). C) Ghost cells and mitotically active basaloid
cells in PMC (H&E, ×400). D) Irregular infiltration of the tumor is present
in the desmoplastic stroma (H&E, ×100).
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It also harbors accessory lacrimal tissue. Hence, neoplasms that may arise from the skin, conjunctiva, and
lacrimal gland may develop in the lacrimal caruncle(7).
None of the cases identified in the PubMed database
reported on the primary hair follicle tumor of the lacrimal caruncle.
Conjunctival involvement is not a typical finding in
hair follicle malignancies. Lee et al.(8) reported a case
of trichilemmal carcinoma of the upper eyelid in a
51-year-old man. They reported that the mass completely penetrated the inner side of the upper lid and
was present on the conjunctival side during slit-lamp
examination. To the best of our knowledge, the present
report is the first description of the PMC of the ocular
surface involving the conjunctiva. In our case, PMC was
originally misdiagnosed as basal cell carcinoma after
incisional biopsy; it was later diagnosed as PMC on the
basis of the excised specimen. This misdiagnosis was
caused by the lack of clear histologic criteria and the
lack of a specific marker to distinguish this neoplasm
from other matrical tumors (5).
Histopathologically, PMCs can be distinguished from
benign pilomatricoma, trichoblastic carcinoma, and
basal cell carcinoma owing to matrical differentiation.
Basal cell carcinoma presents with infiltrating islands
of palisading basaloid cells with shadow cells. Histological examination can be challenging, and malignant
pilomatricoma with many basophilic basal cells is often
mistaken for basal cell carcinoma(9). Differentiation is
dependent upon the observation of retraction spaces
between neoplastic cells and stroma(5,9). In the present
case, there were no retraction artifacts between basaloid
cells and stroma. Furthermore, proliferating pilomatricoma, which is a pathological variant of pilomatricoma
that consists predominantly of mitotically active basaloid cells, should be included in the differential diagnosis.
In such cases, poor circumscription, an asymmetrical
appearance, atypical mitoses, and lymphovascular invasion are features that favor a diagnosis of PMC(10).
PMC can exhibit local aggressive behavior with a tendency toward recurrence. Thus, we administered topical
chemotherapy to prevent recurrence even though the
surgical margins were free of tumor cells. To the best of
our knowledge, this is the first reported case of PMC of
the ocular surface; therefore, there is no standard topical
chemotherapy protocol for similar cases. It has recently
been reported that topical bevacizumab may reduce tumor
size prior to surgery or may completely cure the tumor

in ocular surface squamous neoplasia(11,12). Additionally,
the systemic application of bevacizumab is a treatment
option in PMC when local recurrence and distant metastasis are detected(13). Although the use of topical
bevacizumab as an adjuvant therapy after the surgical
treatment of ocular surface neoplasms is not a proven
treatment option, it is regarded a good and safe option
on the basis of the literature described above. We have
not observed any side effects after three months of continuous treatment with topical bevacizumab.
Local recurrences and metastatic disease have been
documented after the simple excision of these types of
lesions(6). Therefore, the creation of a sufficiently wide
excision with a tumor-free margin is important during
histopathological examination. In our case, after considering the clinical appearance of surgical margins and
the results of the previous biopsy, we concluded that
the resection of the tumor with a 2 mm margin of safety
would ensure its complete removal. A wider excision
could have been made after pathological examination,
but there was a high risk of inadvertently damaging
the canalicular system because of the proximity of the
primary lesion to this system. Furthermore, the patient
would have been required to undergo general anesthesia
because he could not tolerate surgery under local anesthesia, and it would have been more difficult to make
precise excisions because the tumor margin would be
obscured following two previous surgeries in the same
area. The patient was informed of the current situation
and decided not to undergo a second surgical procedure.
Consequently, a second surgery was not performed.
Topical chemotherapy was initiated, and the patient
underwent continuous monitoring.
This case highlights the rare potential for conjunctival
lesions to have unusual origins with potentially serious
consequences. To make accurate excisions during the initial surgery, frozen section examinations should be performed during surgery, and differential diagnosis should
be made with the inclusion of conditions such as PMC.
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